TCRX
Tscan Therapeutics, Inc.
$0.24+0.03 (14.29%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖AI Insight
Latest Insider Transactions
Showing 10 of 11 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Macbeath Gavin | CEO | Award | 1,000,000 | $0.00 | $0 | N/A | N/A |
| 2026-10-02 | 2026-10-01 | Zdraveski Zoran | See Remarks | Award | 300,000 | $0.00 | $0 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Baker Bros. Advisors Lp | Director | Award | 67,000 | $1.00 | $66,665 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Woods Keith | Director | Award | 67,000 | $1.00 | $66,665 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Nicholson Garry A | Director | Award | 67,000 | $1.00 | $66,665 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Gruia Gabriela | Director | Award | 67,000 | $1.00 | $66,665 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Dorton Katina | Director | Award | 67,000 | $1.00 | $66,665 | N/A | N/A |
| 2026-05-22 | 2026-05-20 | Klencke Barbara | Director | Award | 67,000 | $1.00 | $66,665 | N/A | N/A |
| 2025-12-23 | 2025-12-23 | Lynx1 Capital Management Lp | 10% Owner | Purchase | 6,232 | $0.90 | $5,603 | +14.6% | +31.3% |
| 2025-12-23 | 2025-12-22 | Lynx1 Capital Management Lp | 10% Owner | Purchase | 75,500 | $0.90 | $67,950 | +14.4% | +26.7% |
TCRX
10% Owner
Purchase
$5.6K
Lynx1 Capital Management Lp6,232 shares @ $0.90
Filed 2025-12-23Trade 2025-12-23
TCRX
10% Owner
Purchase
$68K
Lynx1 Capital Management Lp75,500 shares @ $0.90
Filed 2025-12-23Trade 2025-12-22
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.